SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026644
Filing Date
2018-11-05
Accepted
2018-11-05 09:01:30
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20180930.htm 10-Q 1764390
2 EX-10.1 pbyi-ex101_178.htm EX-10.1 27667
3 EX-31.1 pbyi-ex311_12.htm EX-31.1 9316
4 EX-31.2 pbyi-ex312_13.htm EX-31.2 9331
5 EX-32.1 pbyi-ex321_10.htm EX-32.1 6281
6 EX-32.2 pbyi-ex322_8.htm EX-32.2 6295
  Complete submission text file 0001564590-18-026644.txt   7032322

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pbyi-20180930.xml EX-101.INS 1666623
8 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20180930.xsd EX-101.SCH 46533
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20180930_cal.xml EX-101.CAL 45932
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20180930_def.xml EX-101.DEF 148497
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20180930_lab.xml EX-101.LAB 398795
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20180930_pre.xml EX-101.PRE 286787
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 181158932
SIC: 2834 Pharmaceutical Preparations